Literature DB >> 16242818

Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.

S Parida1, Y Oh, S M Reid, S J Cox, R J Statham, M Mahapatra, J Anderson, P V Barnett, B Charleston, D J Paton.   

Abstract

Studies were performed to determine whether a rapid method to detect cell mediated immune responses to foot-and-mouth disease virus (FMDV) could be used either as a diagnostic test or provide a correlate of protection in animals post-vaccination. Using protocols based on the BOVIGAM assay for tuberculosis, whole blood samples from FMDV vaccinated or control animals, before and after challenge infection, were stimulated overnight with inactivated FMDV antigen. The quantity of interferon gamma (IFN-gamma) produced in the supernatants was measured using an ELISA. Specific induction of IFN-gamma was detected in samples from vaccinated, infected and vaccinated-then-infected cattle. Further development of this assay may provide a useful tool for the diagnosis of FMDV immune animals, including the identification of vaccinated animals that have been subsequently infected with FMDV. In these studies, combining the results of the IFN-gamma assay with virus neutralising antibody titre, in groups of vaccinated animals, provided a correlation with the capacity to control virus replication after subsequent challenge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242818     DOI: 10.1016/j.vaccine.2005.08.108

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination.

Authors:  Efrain Guzman; Geraldine Taylor; Bryan Charleston; Shirley A Ellis
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

2.  Hsp70 enhances presentation of FMDV antigen to bovine CD4+ T cells in vitro.

Authors:  Kerry McLaughlin; Julian Seago; Lucy Robinson; Charles Kelly; Bryan Charleston
Journal:  Vet Res       Date:  2010-02-02       Impact factor: 3.683

3.  Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease.

Authors:  Julie Perkins; Satya Parida; Alfonso Clavijo
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

4.  Comparative study of experimental Foot-and-Mouth Disease in cattle (Bos indicus) and buffaloes (Bubalis bubalus).

Authors:  Mohan S Maddur; M S Mohan; M R Gajendragad; S Gopalakrishna; Nem Singh
Journal:  Vet Res Commun       Date:  2008-05-20       Impact factor: 2.459

5.  Immune response and viral persistence in Indian buffaloes (Bubalus bubalis) infected with foot-and-mouth disease virus serotype Asia 1.

Authors:  Mohan S Maddur; Subodh Kishore; S Gopalakrishna; Nem Singh; V V Suryanarayana; Mukund R Gajendragad
Journal:  Clin Vaccine Immunol       Date:  2009-10-14

6.  Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock.

Authors:  David J Paton; Geraldine Taylor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

7.  Interferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection.

Authors:  Yooni Oh; Lucy Fleming; Bob Statham; Pip Hamblin; Paul Barnett; David J Paton; Jong-Hyeon Park; Yi Seok Joo; Satya Parida
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines.

Authors:  Andy Haegeman; Ilse De Leeuw; Laurent Mostin; Willem Van Campe; Laetitia Aerts; Estelle Venter; Eeva Tuppurainen; Claude Saegerman; Kris De Clercq
Journal:  Vaccines (Basel)       Date:  2021-05-08

9.  Development and Validation of a Mucosal Antibody (IgA) Test to Identify Persistent Infection with Foot-and-Mouth Disease Virus.

Authors:  Jitendra K Biswal; Antonello Di Nardo; Geraldine Taylor; David J Paton; Satya Parida
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

10.  Requirements for improved vaccines against foot-and-mouth disease epidemics.

Authors:  Jong-Hyeon Park
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.